50 related articles for article (PubMed ID: 17525212)
1. Basic fibroblast growth factor impact on retinoblastoma progression and survival.
Cebulla CM; Jockovich ME; Piña Y; Boutrid H; Alegret A; Kulak A; Hackam AS; Bhattacharya SK; Feuer WJ; Murray TG
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5215-21. PubMed ID: 18614803
[TBL] [Abstract][Full Text] [Related]
2. Forced Trefoil Factor Family Peptide 3 (TFF3) Expression Reduces Growth, Viability, and Tumorigenicity of Human Retinoblastoma Cell Lines.
Große-Kreul J; Busch M; Winter C; Pikos S; Stephan H; Dünker N
PLoS One; 2016; 11(9):e0163025. PubMed ID: 27626280
[TBL] [Abstract][Full Text] [Related]
3. A Substance P (SP)/Neurokinin-1 Receptor Axis Promotes Perineural Invasion of Pancreatic Cancer and Is Affected by lncRNA LOC389641.
Ji T; Ma K; Wu H; Cao T
J Immunol Res; 2022; 2022():5582811. PubMed ID: 35600049
[TBL] [Abstract][Full Text] [Related]
4. Significance of the Overexpression of Substance P and Its Receptor NK-1R in Head and Neck Carcinogenesis: A Systematic Review and Meta-Analysis.
González-Moles MÁ; Ramos-García P; Esteban F
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33802704
[TBL] [Abstract][Full Text] [Related]
5. miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer.
Zhou Y; Wang M; Tong Y; Liu X; Zhang L; Dong D; Shao J; Zhou Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819875168. PubMed ID: 31506061
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine Factors and Head and Neck Squamous Cell Carcinoma: An Affair to Remember.
Solomon I; Voiculescu VM; Caruntu C; Lupu M; Popa A; Ilie MA; Albulescu R; Caruntu A; Tanase C; Constantin C; Neagu M; Boda D
Dis Markers; 2018; 2018():9787831. PubMed ID: 29854027
[TBL] [Abstract][Full Text] [Related]
7. Varicella Zoster Virus Induces Nuclear Translocation of the Neurokinin-1 Receptor, Promoting Lamellipodia Formation and Viral Spread in Spinal Astrocytes.
Bubak AN; Como CN; Blackmon AM; Frietze S; Mescher T; Jones D; Cohrs RJ; Paucek P; Baird NL; Nagel MA
J Infect Dis; 2018 Sep; 218(8):1324-1335. PubMed ID: 29788447
[TBL] [Abstract][Full Text] [Related]
8. An RNA interference screen identifies new avenues for nephroprotection.
Zynda ER; Schott B; Babagana M; Gruener S; Wernher E; Nguyen GD; Ebeling M; Kandel ES
Cell Death Differ; 2016 Apr; 23(4):608-15. PubMed ID: 26564400
[TBL] [Abstract][Full Text] [Related]
9. The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.
Munoz M; Covenas R; Esteban F; Redondo M
J Biosci; 2015 Jun; 40(2):441-63. PubMed ID: 25963269
[TBL] [Abstract][Full Text] [Related]
10. Involvement of substance P and the NK-1 receptor in pancreatic cancer.
Muñoz M; Coveñas R
World J Gastroenterol; 2014 Mar; 20(9):2321-34. PubMed ID: 24605029
[TBL] [Abstract][Full Text] [Related]
11. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.
Steinhoff MS; von Mentzer B; Geppetti P; Pothoulakis C; Bunnett NW
Physiol Rev; 2014 Jan; 94(1):265-301. PubMed ID: 24382888
[TBL] [Abstract][Full Text] [Related]
12. The NK-1 Receptor Antagonist L-732,138 Induces Apoptosis and Counteracts Substance P-Related Mitogenesis in Human Melanoma Cell Lines.
Muñoz M; Rosso M; González-Ortega A; Coveñas R
Cancers (Basel); 2010 Apr; 2(2):611-23. PubMed ID: 24281084
[TBL] [Abstract][Full Text] [Related]
13. Walker 256 tumour cells increase substance P immunoreactivity locally and modify the properties of the blood-brain barrier during extravasation and brain invasion.
Lewis KM; Harford-Wright E; Vink R; Nimmo AJ; Ghabriel MN
Clin Exp Metastasis; 2013 Jan; 30(1):1-12. PubMed ID: 22610781
[TBL] [Abstract][Full Text] [Related]
14. The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer.
Rosso M; Muñoz M; Berger M
ScientificWorldJournal; 2012; 2012():381434. PubMed ID: 22545017
[TBL] [Abstract][Full Text] [Related]
15. The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines.
Muñoz M; González-Ortega A; Coveñas R
Invest New Drugs; 2012 Apr; 30(2):529-40. PubMed ID: 21120581
[TBL] [Abstract][Full Text] [Related]
16. SR140333 counteracts NK-1 mediated cell proliferation in human breast cancer cell line T47D.
Huang WQ; Wang JG; Chen L; Wei HJ; Chen H
J Exp Clin Cancer Res; 2010 May; 29(1):55. PubMed ID: 20497542
[TBL] [Abstract][Full Text] [Related]
17. The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug.
Muñoz M; Rosso M
Invest New Drugs; 2010 Apr; 28(2):187-93. PubMed ID: 19148578
[TBL] [Abstract][Full Text] [Related]
18. NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2.
Muñoz M; Rosso M; Aguilar FJ; González-Moles MA; Redondo M; Esteban F
Invest New Drugs; 2008 Apr; 26(2):111-8. PubMed ID: 17906845
[TBL] [Abstract][Full Text] [Related]
19. Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonist, L-732,138.
Muñoz M; Rosso M; Coveñas R; Montero I; González-Moles MA; Robles MJ
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2775-81. PubMed ID: 17525212
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
